Hyperammonemia after lung transplantation is a rare complication of unknown etiology. Its management is largely supportive and outcomes have been variable. More disconcerting is its immunosuppressive management because the precipitating factors leading to this potentially lethal entity are unknown, but are suspected to be drug-related. We describe the successful management of a lung transplant recipient with severe hyperammonemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.healun.2008.03.019 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!